Drug Detail:Dalfampridine (Dalfampridine [ dal-fam-pri-deen ])
Drug Class: Miscellaneous central nervous system agents
Dalfampridine Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because no information is available on the use of dalfampridine during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Dalfampridine
CAS Registry Number
504-24-5
Drug Class
-
Breastfeeding
-
Lactation
-
Neuromuscular Agents
-
Potassium Channel Blockers
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification